Gleevec
NDC 0078-1490, imatinib mesylate, tablet, from Novartis Pharmaceuticals Corporation.
- Product NDC
- 0078-1490
- Status
- Listed
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021588
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1490 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IMATINIB MESYLATE400 mg/1
Pharmacologic classes
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0078-1490-13 | 00078149013 | 3 BLISTER PACK in 1 CARTON (0078-1490-13) / 10 TABLET in 1 BLISTER PACK (0078-1490-26) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/211ef2da-2868-4a77-8055-1cb2cd78e24b
Use it
Look up 0078-1490 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1490 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0078-1490. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.